Harmless virus levels may predict transplant complications
NCT ID NCT05836636
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 172 kidney transplant recipients who were on stable anti-rejection medication for at least 3 months. Researchers measured levels of a common, harmless virus (Torque Teno Virus) in their blood to see if it could predict serious infections or organ rejection. The goal was to find a simple test that helps doctors personalize medication and improve long-term outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Singapore General Hospital
Singapore, Singapore, 767972, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vaccine shield transplant patients from shingles?
- Can your gut bacteria change how transplant drugs work?
- Can a single drug dose forecast transplant kidney health?
- Your gut bacteria might predict transplant rejection
- Pre-Surgery bootcamp may boost kidney transplant recovery
- Engineered immune cells aim to trick the body into accepting a new kidney